The diagnosis of CPT2 deficiency is based on elevated levels of C12- to C18-ACs, specifically increased levels of C16- and C18:1-ACs and reduced levels of free carnitine. This evidence concerns the gene CPT2 and hyperinsulinemic hypoglycemia, familial, 4.